Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
Tag: IP newsletter
Dodged bullet or missed opportunity with CHEO settlement?: Richard Owens for the MLI IP newsletter
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
Stop the TPP-IP media pile-on: Richard Owens for the MLI IP newsletter
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
Top News
-
The Rupture Cycle – Commodities, geopolitics, and Canada’s moment: Heather Exner-Pirot
-
How Canada’s skilled immigration system went off the rails – and how to fix it: Nino Melikidze and Steven Paolasini
-
Rebalancing Canada: A two-pillar reform of equalization and federal transfers
-
Canada’s conversation about new submarines is failing to ask the most important question: Rob Huebert in The Globe and Mail
-
United in hate – The unlikely “red–green–brown” alliance behind rising antisemitism in Canada: Sheryl Saperia and Ches W. Parsons
